(Allergan plc)

	AGN latest price $260.0441 (-1.2%) ($257.9690 - $265.1587) on Fri. Mar. 18, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.75% (three month average)
RSI	35
Latest Price	$260.0441(-1.2%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -2.1% a day on average for past five trading days.
Weekly Trend	AGN declines -2.4% a week on average for past two weeks.
Market Behavior	Value stock rally for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(51%)    XLV(50%)    XBI(45%)    ARKG(41%)    SPY(41%)
Factors Impacting AGN price	AGN will decline at least -0.875% in a week (0% probabilities).   VIXM(-29%)    TLT(-16%)    UUP(-12%)    SHY(-5%)    XME(-4%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.875% (StdDev 1.75%)
Hourly BBV	0 ()
Intraday Trend	-1.7%

Resistance Level	$277.25
5 Day Moving Average	$268.49(-3.15%)
10 Day Moving Average	$273.91(-5.06%)
20 Day Moving Average	$277.25(-6.21%)
To recent high	-14.5%
To recent low	1.2%
Market Cap	$85.737b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed